Long‐term prophylaxis with hepatitis B immunoglobulin (HBIG) for the prevention of hepatitis
B virus (HBV) recurrence after orthotopic liver transplantation (OLT) in patients with chronic …

BACKGROUND: Hepatitis B immunoglobulin (HBIG) given in combination with a nucleos (t)
ide analogue has reduced the rate of recurrent hepatitis B virus (HBV) infection following …

Background Hepatitis B immune globulin (HBI g) with or without nucleos (t) ide analogue
(NA) inhibitors has been shown to prevent recurrence of hepatitis B virus (HBV) following …

Background After orthotopic liver transplantation (OLT) in chronic hepatitis B (HBV),
adequate prophylaxis for recurrence of HBV in the graft is mandatory. Objectives Evaluate …

Background and aims Combination of hepatitis B immunoglobulin (HBIG) and a nucleos (t)
ide analog (NA) is considered the standard of care for prophylaxis of hepatitis B virus (HBV) …

Background Recent data suggest that oral third-generation nucleos (t) ide analogs (NA)
monoprophylaxis following hepatitis B immunoglobulin (HBIg) withdrawal may be effective …

Orthotopic liver transplantation (OLT) for hepatitis B virus (HBV) infection was limited until
recently by poor graft and patient outcomes caused by recurrent HBV. Long-term …

Passive immunoprophylaxis with hepatitis B immunoglobulin (HBIG) is important to prevent
recurrence of hepatitis B virus (HBV) after orthotopic liver transplantation (OLT) for chronic …

Background The long‐term impact of oral hepatitis B antiviral therapy in liver transplant (LT)
recipients is currently underexplored. The objective of this study was to evaluate how oral …

The advance in treatment against hepatitis B virus (HBV) infection with the development of
nucleos (t) ide analogues (NAs) with high genetic barrier to resistance, including entecavir …